Skip to main content

Glipizide Tablet, Extended Release Shortage

Last Updated: July 24, 2025
Status: Discontinued

To Be Discontinued:

Glipizide, Tablet, Extended Release, 10 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0591-0845-01
Status: To Be Discontinued
Date of update: February 6, 2025
Update type: New
Related Information: A business decision was made to discontinue manufacture of the drug.
Therapeutic category: Endocrinology/Metabolism
Date discontinued: February 6, 2025
Initial posting date: February 6, 2025
Contact info: 800-545-8800

Glipizide, Tablet, Extended Release, 10 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0591-0845-10
Status: To Be Discontinued
Date of update: February 6, 2025
Update type: New
Related Information: A business decision was made to discontinue manufacture of the drug.
Therapeutic category: Endocrinology/Metabolism
Date discontinued: February 6, 2025
Initial posting date: February 6, 2025
Contact info: 800-545-8800

Glipizide, Tablet, Extended Release, 2.5 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0591-0900-30
Status: To Be Discontinued
Date of update: February 6, 2025
Update type: New
Related Information: A business decision was made to discontinue manufacture of the drug.
Therapeutic category: Endocrinology/Metabolism
Date discontinued: February 6, 2025
Initial posting date: February 6, 2025
Contact info: 800-545-8800

Glipizide, Tablet, Extended Release, 5 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0591-0844-01
Status: To Be Discontinued
Date of update: February 6, 2025
Update type: New
Related Information: A business decision was made to discontinue manufacture of the drug.
Therapeutic category: Endocrinology/Metabolism
Date discontinued: February 6, 2025
Initial posting date: February 6, 2025
Contact info: 800-545-8800

Glipizide, Tablet, Extended Release, 5 mg (Teva Pharmaceuticals USA, Inc.)

NDC Code: 0591-0844-10
Status: To Be Discontinued
Date of update: February 6, 2025
Update type: New
Related Information: A business decision was made to discontinue manufacture of the drug.
Therapeutic category: Endocrinology/Metabolism
Date discontinued: February 6, 2025
Initial posting date: February 6, 2025
Contact info: 800-545-8800

Glucatrol XL, Tablet, Extended Release, 10 mg tablets; bottle of 500 (Pfizer Inc.)

NDC Code: 0049-0178-08
Status: To Be Discontinued
Date of update: July 24, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Endocrinology/Metabolism
Date discontinued: July 24, 2025
Initial posting date: July 24, 2025
Contact info: 800-533-4535

Glucotrol XL, Tablet, Extended Release, 5 mg (Pfizer Inc.)

NDC Code: 0049-0174-03
Status: To Be Discontinued
Date of update: March 17, 2025
Update type: New
Related Information: Supply expected to exhaust early April 2025
Therapeutic category: Endocrinology/Metabolism
Date discontinued: March 17, 2025
Initial posting date: March 17, 2025
Contact info: 800-533-4535

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer